These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 35678906

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. New insights into the transcriptional regulation of aquaporin-2 and the treatment of X-linked hereditary nephrogenic diabetes insipidus.
    Jung HJ, Kwon TH.
    Kidney Res Clin Pract; 2019 Jun 30; 38(2):145-158. PubMed ID: 31189221
    [Abstract] [Full Text] [Related]

  • 23. New developments and concepts in the diagnosis and management of diabetes insipidus (AVP-deficiency and resistance).
    Angelousi A, Alexandraki KI, Mytareli C, Grossman AB, Kaltsas G.
    J Neuroendocrinol; 2023 Jan 30; 35(1):e13233. PubMed ID: 36683321
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Central diabetes insipidus associated with impaired renal aquaporin-1 expression in mice lacking liver X receptor β.
    Gabbi C, Kong X, Suzuki H, Kim HJ, Gao M, Jia X, Ohnishi H, Ueta Y, Warner M, Guan Y, Gustafsson JÅ.
    Proc Natl Acad Sci U S A; 2012 Feb 21; 109(8):3030-4. PubMed ID: 22323586
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Genetics of Diabetes Insipidus.
    Schernthaner-Reiter MH, Stratakis CA, Luger A.
    Endocrinol Metab Clin North Am; 2017 Jun 21; 46(2):305-334. PubMed ID: 28476225
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Nephrogenic diabetes insipidus associated with mutations of vasopressin V2 receptors and aquaporin-2].
    Ishikawa SE.
    Nihon Rinsho; 2002 Feb 21; 60(2):350-5. PubMed ID: 11857925
    [Abstract] [Full Text] [Related]

  • 36. Congenital nephrogenic diabetes insipidus: the current state of affairs.
    Wesche D, Deen PM, Knoers NV.
    Pediatr Nephrol; 2012 Dec 21; 27(12):2183-204. PubMed ID: 22427315
    [Abstract] [Full Text] [Related]

  • 37. Radioimmunoassay of arginine-vasopressin in human urine and its use in physiological and pathological states.
    Khokhar AM, Ramage CM, Slater JD.
    J Endocrinol; 1978 Dec 21; 79(3):375-89. PubMed ID: 744931
    [Abstract] [Full Text] [Related]

  • 38. Epac1 null mice have nephrogenic diabetes insipidus with deficient corticopapillary osmotic gradient and weaker collecting duct tight junctions.
    Sivertsen Åsrud K, Bjørnstad R, Kopperud R, Pedersen L, van der Hoeven B, Karlsen TV, Brekke Rygh C, Curry FR, Bakke M, Reed RK, Tenstad O, Døskeland SO.
    Acta Physiol (Oxf); 2020 May 21; 229(1):e13442. PubMed ID: 31943825
    [Abstract] [Full Text] [Related]

  • 39. A mini-review of pharmacological strategies used to ameliorate polyuria associated with X-linked nephrogenic diabetes insipidus.
    Mortensen LA, Bistrup C, Jensen BL, Hinrichs GR.
    Am J Physiol Renal Physiol; 2020 Nov 01; 319(5):F746-F753. PubMed ID: 32924547
    [Abstract] [Full Text] [Related]

  • 40. Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis.
    Saito T, Higashiyama M, Nagasaka S, Sasaki S, Saito T, Ishikawa SE.
    Kidney Int; 2001 Oct 01; 60(4):1266-76. PubMed ID: 11576341
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.